Redox, redux: Journal pulls paper over data problems

Antioxidants & Redox Signalling has issued much more detailed retraction notice for a paper it pulled last year that was marred by duplicate data.

As we reported then, the journal’s initial notice for the 2011 article, titled “Inhibition of LXRa-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation,” was underwhelming:

THIS WORK HAS BEEN RETRACTED BY THE AUTHORS

Although we learned at the time that a reader, Paul Brookes, of the University of Rochester, had raised concerns about the article to the editors of ARS and other publications, we were glad to see that ARS has decided to make a clean breast of matters. The study has been cited by other papers three times, according to Thomson Scientific’s Web of Knowledge.

Here’s the notice, from editor Chandan K. Sen: Continue reading Redox, redux: Journal pulls paper over data problems

Journal pulls four breast cancer papers for duplication

The journal Breast Cancer: Targets and Therapy, a Dove Medical Press title, has retracted four articles from a group of Indian researchers over what it said were “unacceptable levels” of duplication with other published work. (Such a construction leaves us wondering what might constitute “acceptable levels” of duplication, but that’s for a different post.)

The articles were submitted by Rajeev Singhai, who is listed as being with Grant Medical College and the Sir J J Group of Hospitals, in Mumbai. According to his After College page, Singhai received his PhD in 2011 and is now a research fellow.

As the notice states: Continue reading Journal pulls four breast cancer papers for duplication

Journal yanks anemia paper over duplicate data

Blood Cells, Molecules, and Diseases (that’s one title) has retracted a 2011 paper, “Comparative proteomics reveals deficiency of NHE-1 (Slc9a1) in RBCs from the beta-adducin knockout mouse model of hemolytic anemia,” after learning from a reader that the data it contained were previously published by a competing publication.

As the notice explains: Continue reading Journal yanks anemia paper over duplicate data

Neuro journal retracts case study with redundant data

If that headline has you scratching your, well, head, we don’t blame you. After all, case studies are, by definition, unique — but not this one.

Neurological Sciences, the official journal of the Italian Society of Neurology, has retracted a 2009 article by a Korean scientist after learning that the manuscript contained elements of a 2007 publication in a different publication.

According to the notice: Continue reading Neuro journal retracts case study with redundant data

Gastro journal retracts duplicate review, but what really happened?

Current Opinion in Gastroenterology is a bimonthly journal “offering a unique and wide ranging perspective on the key developments in the field” that “features hand-picked review articles from our team of expert editors.”

Apparently, those hands picked what amounted to the same “unique” article twice. The journal is retracting a 2004 paper, “Enteral feeding,” by Khursheed Jeejeebhoy, an expert in nutrition at the University of Toronto (he’s now emeritus), because it duplicates a 2003 paper with the same title.

Here’s what the notice, which, lamentably, sits behind a paywall, has to say: Continue reading Gastro journal retracts duplicate review, but what really happened?

“Failure probability” turns out to be quite high as engineers double-submit paper, then see it retracted

A couple of engineers in Iran turn out to be better at predicting the “failure probability” of water pipes than of their chances of being published.

Consider this retraction notice for “Estimation of failure probability in water pipes network using statistical model,” originally published in February 2011 in Engineering Failure Analysis: Continue reading “Failure probability” turns out to be quite high as engineers double-submit paper, then see it retracted

Duplication forces retraction of paper by group whose work is used to justify prostate-specific antigen (PSA) testing

A dozen years might seem like a publishing eternity, but the European Journal of Cancer has decided to purge a duplicate paper from 2000. The article, on the utility of the prostate-specific antigen (PSA) test for detecting prostate cancer, comes from a group whose work in this area has been widely cited as evidence for the benefits of the highly controversial screening tool.

“Prostate cancer screening in the Tyrol, Austria: experience and results,” by a group of Austrian researchers, has a rather complicated past. It’s been cited 42 times, according to Thomson Scientific’s Web of Knowledge. Here’s the notice, which appeared in a recent issue of the journal: Continue reading Duplication forces retraction of paper by group whose work is used to justify prostate-specific antigen (PSA) testing

Rabies paper retracted for plagiarism, and more from the Journal of Clinical Pathology

A cardinal (if oft-broken) rule of headline writing is to avoid the use of question marks. We think it’s particularly important to do so when the potential for ironic misadventure lurks.

To wit: The Journal of Clinical Pathology (JCP) has withdrawn/retracted a 2008 paper by a group of Indian authors (from the National Institute of Mental Health and Neuro Sciences, at Deemed University) whose cliff-hanging title asks the question “Tracking the footprints of the rabies virus: are we any closer to decoding this elusive virus?” Continue reading Rabies paper retracted for plagiarism, and more from the Journal of Clinical Pathology

No small matter: ACS Nano journal growing alarmed by self-plagiarism

Is self-plagiarism — perhaps best referred to as duplication of your own work — a big problem in nanotechnology research?

The American Chemical Society (ACS) Nano journal retracted a study, “Retraction of Nanoembossing Induced Ferroelectric Lithography on PZT Films for Silver Particle Patterning,”  late last month because of such duplication:

This article was withdrawn at the request of the Editor-in-Chief, with agreement by the authors, due to unacceptable redundant text and figures with a previously published article by the same authors (Langmuir 2011, 27, 5167-5170. DOI: 10.1021/la200377b).

This wasn’t the first such retraction for the journal. In May, they retracted “Conductance Preservation of Carbene-Functionalized Metallic Single-Walled Carbon Nanotubes for the same reason:” Continue reading No small matter: ACS Nano journal growing alarmed by self-plagiarism

Seeing double: Current Eye Research retracts three papers for duplication

Three papers in Current Eye Research have apparently not quite lived up to the journal’s name. The journal in November retracted three studies from a group of authors in China who had previously published the papers in their native language.

Here’s the notice, which also appears in this month’s print edition: Continue reading Seeing double: Current Eye Research retracts three papers for duplication